Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.105
Bid: 0.10
Ask: 0.105
Change: -0.002 (-1.91%)
Spread: 0.005 (5.00%)
Open: 0.1005
High: 0.105
Low: 0.1005
Prev. Close: 0.1045
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Medical Technology Collaboration

21 Feb 2018 07:00

RNS Number : 4572F
Versarien PLC
21 February 2018
 

Versarien plc

("Versarien" or the "Company")

Medical Technology Collaboration

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce that it has signed an agreement to develop a range of graphene based sensor technologies to enable the creation of digital bandages and wound dressings capable of various forms of physiological movement and excretion detection.

This project will utilise strain sensors printed with graphene ink using methods which have been developed by the Company's subsidiary, Cambridge Graphene Limited. Trials will take place at the internationally renowned Addenbrooke's Hospital in Cambridge with Orthopaedic surgeon Dr Arman Memanzedah leading the clinical trials. He will be joined by Dr Simon Rudland from Stowhealth who will be working with the team to optimise the usability of the data from the graphene dressings to ensure the optimal recovery of the patients post discharge. The agreement will also involve Dr Chris Crockford, Managing Director of Digital and Future Technologies Limited, who will act as liaison between the hospital, Versarien and wider global providers in this field.

Neill Ricketts, CEO of Versarien, commented: "We are very pleased to be working to bring our graphene ink technology to the medical arena. This is our first collaboration in this area and we anticipate that the properties of the high quality graphene we produce can bring significant benefits. In particular, the incorporation of graphene inks will enable the development of 'smart' wound dressings, facilitating better patient monitoring and enhanced recovery.

"We are very excited about the potential for graphene in a variety of medical uses and anticipate entering into further collaborations in this area in due course."

 

Enquiries:

Versarien 01242 269 122

Neill Ricketts, CEO

Chris Leigh, CFO

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe

Ed Allsopp

IFC Advisory (Financial PR and IR) 0203 934 6630

Tim Metcalfe

Graham Herring

Heather Armstrong

 

About Versarien

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has five subsidiaries operating under two divisions:

Graphene and Plastics

2-DTech Ltd, which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

ACC Cyroma Ltd, which specialises in the supply of vacuum-formed and injection-moulded products to the automotive, construction, utilities and retail industry sectors. Using Versarien's existing graphene manufacturing capabilities, AAC will have the ability to produce graphene-enhanced plastic products. www.aaccyroma.co.uk  

Cambridge Graphene Ltd, which supplies novel inks based on graphene and related materials, using patented processes and develops graphene materials technology for licensing to manufacturers. www.cambridgegraphene.com 

Thermal and Hard Wear Products

Versarien Technologies Ltd. which owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals targeting the thermal management industry and manufactures extruded aluminium heat sinks for the electronics and computing industries. www.versarien-technologies.co.uk 

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABBLLLVLFEBBQ
Date   Source Headline
22nd Jul 20147:00 amRNSFinal Results
8th Jul 20147:00 amRNSNotice of Preliminary Results
30th Jun 20143:08 pmRNSTotal Voting Rights
17th Jun 20143:05 pmRNSIssue of Equity
6th May 201410:35 amRNSHolding(s) in Company
2nd May 20144:43 pmRNSHolding(s) in Company
2nd May 20143:22 pmRNSHolding(s) in Company
30th Apr 20144:33 pmRNSHolding(s) in Company
30th Apr 201412:07 pmRNSResult of General Meeting
28th Apr 201411:17 amRNSHolding(s) in Company
16th Apr 20144:52 pmRNSHolding(s) in Company
14th Apr 20147:00 amRNSAcquisition of 2-DTech Limited & £5.5m Placing
10th Apr 20147:00 amRNSChange of Adviser
19th Mar 20147:00 amRNSTrading Update
19th Feb 20147:00 amRNSHolding(s) in Company
19th Feb 20147:00 amRNSHolding(s) in Company
3rd Feb 20147:00 amRNSHolding(s) in Company
27th Jan 20148:30 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSInvestor Site Visit
11th Dec 20138:46 amRNSHolding(s) in Company
3rd Dec 20137:00 amRNSInterim Results
3rd Oct 20137:00 amRNSDistribution Agreement
1st Oct 20134:24 pmRNSDirector/PDMR Shareholding
30th Sep 201310:30 amRNSVersarien Launches its First Ever Water-Cooled PC
27th Sep 20137:00 amRNSFinal Results
21st Aug 20139:00 amRNSNotification of Shareholding
16th Aug 20137:00 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSCEO to join GFirst board
16th Jul 20137:00 amRNSGrant awarded from Technology Strategy Board
3rd Jul 20139:00 amRNSAppointment of Finance Director
12th Jun 20137:00 amRNSAIM Admission

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.